The Hartford Healthcare Fd Cl Y (HGHYX)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
The Hartford Healthcare Fd Cl Y (HGHYX) trades at $48.04. The Hartford Healthcare Fd Cl Y (HGHYX) is a mutual fund focused on long-term capital appreciation through investments in global healthcare companies. Market cap: $731.80M, Sector: Financial services.
Last analyzed: Mar 17, 2026Analyst Coverage for HGHYX: HGHYX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HGHYX against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
HGHYX: 1/1 perspectives are bearish.
The Hartford Healthcare Fd Cl Y (HGHYX) Financial Services Profile
The Hartford Healthcare Fd Cl Y (HGHYX) is a mutual fund with an $0.85 billion market cap, strategically investing in a diverse portfolio of global healthcare companies. Managed by Wellington Management, the fund targets long-term capital appreciation across pharmaceuticals, biotechnology, and medical services, offering investors exposure to the healthcare sector.
What Is the Investment Thesis for HGHYX?
The Hartford Healthcare Fd Cl Y presents an investment opportunity for those seeking exposure to the global healthcare sector with a focus on long-term capital appreciation. With a beta of 0.77, the fund exhibits lower volatility compared to the broader market, potentially offering a more stable investment option. The fund's strategy of investing at least 80% of its assets in healthcare equities, managed by Wellington Management, provides access to a diversified portfolio across various healthcare subsectors. Key growth catalysts include the aging global population, advancements in medical technology, and increasing healthcare spending worldwide. However, investors may want to evaluate potential risks such as regulatory changes, competition within the healthcare industry, and market fluctuations. While the fund does not offer a dividend yield, its focus on capital appreciation may appeal to investors seeking long-term growth.
Based on FMP financials and quantitative analysis
HGHYX Key Highlights
- The Hartford Healthcare Fd Cl Y has a market capitalization of $0.85 billion, indicating a mid-sized fund within the asset management landscape.
- The fund's beta of 0.77 suggests lower volatility compared to the overall market, potentially offering a more stable investment experience.
- The fund invests at least 80% of its assets in equity securities of healthcare-related companies worldwide, demonstrating a focused approach to the healthcare sector.
- Wellington Management Company LLP serves as the sub-adviser, bringing expertise in healthcare investing to the fund's management.
- The fund's investment strategy encompasses a broad range of healthcare subsectors, including pharmaceuticals, biotechnology, and medical services, providing diversification within the healthcare industry.
Who Are HGHYX's Competitors?
Who Are HGHYX's Competitors?
HGHYX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AOGIX American Century One Choice Portfolio: Aggressive Investor Class | $18.05 | +0.11% | $915.67M | 44 |
| AREVX American Century Investments One Choice 2055 Portfolio | $18.53 | +0.00% | $717.43M | 44 |
| BASAX Brown Advisory Small Cap Growth Adv Shares | $19.93 | +0.00% | $560.52M | 44 |
| BCSAX BlackRock Commodity Strategies Portfolio | $12.02 | +0.17% | $1.27B | 50 |
| BIASX Brown Advisory Small-Cap Growth Fd Investor Shs | $21.22 | +0.00% | $560.52M | 44 |
| SII Sprott Inc. | $131.01 | +3.20% | $3.38B | 71 |
| IDKFF ThreeD Capital Inc. | $0.08 | +0.00% | $5.72M | 70 |
| TPZ Tortoise Electrification Infrastructure ETF | $21.67 | +0.00% | $127.64M | 70 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HGHYX's Key Strengths?
- Experienced sub-adviser (Wellington Management).
- Diversified portfolio across healthcare subsectors.
- Global investment scope.
- Focus on long-term capital appreciation.
What Are HGHYX's Weaknesses?
- No dividend yield.
- Reliance on the performance of the healthcare sector.
- Potential for regulatory changes to impact investments.
- Susceptibility to market fluctuations.
What Could Drive HGHYX Stock Higher?
- Positive clinical trial results for companies in the portfolio.
- Increasing healthcare spending in developed and emerging markets.
- Advancements in medical technology driving innovation in the healthcare sector.
What Are the Key Risks for HGHYX?
- Regulatory changes impacting the healthcare industry.
- Economic downturns reducing healthcare spending.
- Competition within the healthcare sector.
- Market fluctuations affecting the value of investments.
What Are the Growth Opportunities for HGHYX?
- Aging Global Population: The increasing global population, particularly the aging demographic, is driving demand for healthcare services and products. This demographic shift presents a significant growth opportunity for companies in the healthcare sector. HGHYX, with its focus on healthcare equities, is well-positioned to benefit from this trend. The global aging population is expected to continue growing, creating a sustained demand for healthcare investments. This ongoing trend provides a long-term growth catalyst for the fund, potentially leading to increased asset values and investor returns.
- Advancements in Medical Technology: Rapid advancements in medical technology, including areas such as gene therapy, precision medicine, and digital health, are transforming the healthcare landscape. These innovations are creating new opportunities for companies to develop and commercialize novel treatments and diagnostic tools. HGHYX's investment strategy, which encompasses a broad range of healthcare subsectors, allows it to capitalize on these technological advancements. The fund's exposure to innovative companies in areas like biotechnology and medical devices positions it to benefit from the growth potential of these emerging technologies.
- Increasing Healthcare Spending: Healthcare spending is rising globally, driven by factors such as increasing incomes, expanding health insurance coverage, and the development of new and expensive treatments. This trend is creating a favorable environment for companies in the healthcare sector. HGHYX's focus on healthcare equities allows it to participate in this growth. As healthcare spending continues to increase, the fund's investments in healthcare companies are likely to benefit, potentially leading to higher returns for investors. The fund's global investment scope allows it to access opportunities in both developed and emerging markets, further enhancing its growth potential.
- Expansion in Emerging Markets: Emerging markets are experiencing rapid economic growth and increasing access to healthcare services. This expansion is creating new opportunities for healthcare companies to expand their operations and reach new customers. HGHYX's global investment strategy allows it to capitalize on these opportunities. By investing in healthcare companies that are expanding into emerging markets, the fund can benefit from the growth potential of these regions. The fund's exposure to emerging markets provides diversification and the potential for higher returns compared to investments solely focused on developed markets.
- Focus on Preventative Care: There is a growing emphasis on preventative care and wellness, driven by the desire to reduce healthcare costs and improve health outcomes. This trend is creating new opportunities for companies that offer preventative care services and products. HGHYX's investment strategy, which includes exposure to areas such as health information services and managed health care, allows it to participate in this trend. As preventative care becomes more prevalent, the fund's investments in companies focused on wellness and prevention are likely to benefit, potentially leading to increased asset values and investor returns.
What Opportunities Does HGHYX Have?
- Aging global population driving healthcare demand.
- Advancements in medical technology creating new investment opportunities.
- Increasing healthcare spending worldwide.
- Expansion in emerging markets.
What Threats Does HGHYX Face?
- Competition from other healthcare-focused funds.
- Economic downturns impacting healthcare spending.
- Regulatory changes affecting the healthcare industry.
- Patent expirations and generic drug competition.
What Are HGHYX's Competitive Advantages?
- Expertise of Wellington Management Company LLP in healthcare investing.
- Diversified portfolio across various healthcare subsectors.
- Global investment scope providing access to opportunities in both developed and emerging markets.
What Does HGHYX Do?
The Hartford Healthcare Fd Cl Y (HGHYX) is a mutual fund managed with the objective of achieving long-term capital appreciation. The fund operates by investing primarily in the equity securities of healthcare-related companies located worldwide. This investment strategy is executed under the guidance of Wellington Management Company LLP, the sub-adviser, which selects companies across a broad spectrum of the healthcare sector. The fund's approach is comprehensive, encompassing investments in various subsectors such as pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, health information services, and emerging health-related areas. The fund's investment mandate requires that at least 80% of its assets be allocated to the equity securities of these healthcare companies. This concentration reflects a focused approach to capitalizing on the growth potential within the healthcare industry. By diversifying across different segments within healthcare, the fund aims to mitigate risk while capturing opportunities for capital appreciation. The fund's global investment scope allows it to access healthcare companies in both developed and emerging markets, further diversifying its portfolio and potentially enhancing returns. The Hartford Healthcare Fd Cl Y provides investors with a vehicle to participate in the growth of the healthcare sector through a professionally managed fund with a broad and diversified investment strategy.
What Products and Services Does HGHYX Offer?
- Invests in equity securities of healthcare-related companies worldwide.
- Targets long-term capital appreciation.
- Allocates at least 80% of its assets to healthcare equities.
- Diversifies investments across various healthcare subsectors.
- Operates under the guidance of Wellington Management Company LLP.
- Provides investors with exposure to the global healthcare sector.
How Does HGHYX Make Money?
- The fund generates revenue through capital appreciation of its investments in healthcare companies.
- It charges management fees to investors for managing the fund's assets.
- The fund's performance is influenced by the performance of the healthcare sector and the specific companies it invests in.
What Industry Does HGHYX Operate In?
The Hartford Healthcare Fd Cl Y operates within the asset management industry, specifically focusing on the healthcare sector. The global healthcare market is experiencing growth driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. The fund competes with other healthcare-focused funds, such as AOGIX, AREVX, BASAX, BCSAX, and BIASX, in attracting investor capital. The competitive landscape is characterized by varying investment strategies, expense ratios, and fund performance. HGHYX aims to differentiate itself through its broad approach to healthcare investing and the expertise of its sub-adviser, Wellington Management.
Who Are HGHYX's Key Customers?
- Individual investors seeking exposure to the healthcare sector.
- Institutional investors looking for long-term capital appreciation.
- Retirement savers seeking diversified investment options.
HGHYX Financials
HGHYX Latest News
No recent news available for HGHYX.
HGHYX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HGHYX.
Price Targets
Wall Street price target analysis for HGHYX.
HGHYX MoonshotScore
What does this score mean?
The MoonshotScore rates HGHYX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Common Questions About HGHYX (Financial Services)
What does The Hartford Healthcare Fd Cl Y do?
The Hartford Healthcare Fd Cl Y is a mutual fund that seeks long-term capital appreciation by investing primarily in the equity securities of healthcare-related companies worldwide. Managed by Wellington Management Company LLP, the fund invests across a broad range of healthcare subsectors, including pharmaceuticals, biotechnology, medical delivery, medical products, medical services, managed health care, and health information services. The fund aims to provide investors with exposure to the growth potential of the global healthcare sector through a diversified portfolio of healthcare equities.
What do analysts say about HGHYX stock?
AI analysis is currently pending for HGHYX, and therefore, a comprehensive analyst consensus is unavailable at this time. However, key valuation metrics to consider include the fund's market capitalization of $0.85 billion and its beta of 0.77, which suggests lower volatility compared to the broader market. Growth considerations include the fund's focus on the healthcare sector, which is expected to experience growth driven by factors such as an aging population and advancements in medical technology. Investors should conduct their own research and consult with a financial advisor before making any investment decisions.
What are the main risks for HGHYX?
The main risks for The Hartford Healthcare Fd Cl Y include regulatory changes impacting the healthcare industry, economic downturns reducing healthcare spending, competition within the healthcare sector, and market fluctuations affecting the value of investments. The fund's performance is also dependent on the expertise of its sub-adviser, Wellington Management Company LLP. Additionally, the fund's focus on the healthcare sector exposes it to specific risks related to drug pricing, patent expirations, and clinical trial failures. Investors should carefully consider these risks before investing in the fund.
How sensitive is HGHYX to changes in healthcare regulations?
As a fund heavily invested in the healthcare sector, HGHYX is sensitive to regulatory changes impacting the pharmaceutical, biotechnology, and medical services industries. Changes in regulations related to drug pricing, FDA approvals, and healthcare reimbursement policies can significantly affect the profitability and growth prospects of companies within the fund's portfolio. These regulatory shifts can lead to volatility in the fund's performance and potentially impact investor returns. The fund's managers must actively monitor and adapt to evolving regulatory landscapes to mitigate these risks.
How does HGHYX incorporate ESG (Environmental, Social, and Governance) factors into its investment decisions?
While specific ESG integration details for HGHYX are not provided, it is increasingly common for asset managers to consider ESG factors in their investment processes. This may involve evaluating the environmental impact, social responsibility, and corporate governance practices of the healthcare companies within the fund's portfolio. By incorporating ESG considerations, the fund aims to identify companies that are better positioned for long-term sustainability and responsible growth. Investors interested in ESG-focused investments should inquire with The Hartford or Wellington Management about the specific ESG criteria used in managing HGHYX.
What are the key factors to evaluate for HGHYX?
Evaluating HGHYX involves reviewing fundamentals, analyst consensus, and risk factors. Key strength: Experienced sub-adviser (Wellington Management). Primary risk to monitor: Regulatory changes impacting the healthcare industry. This is not financial advice.
How frequently does HGHYX data refresh on this page?
HGHYX prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven HGHYX's recent stock price performance?
Recent price movement in The Hartford Healthcare Fd Cl Y (HGHYX) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Experienced sub-adviser (Wellington Management). Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending, limiting the depth of insights.
- Financial data is based on available information and may not be fully comprehensive.